PMC - Pharmerica Corporation

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Moody's

    Phoenix Guarantor Inc. -- Moody's announces completion of a periodic review of ratings of Phoenix Guarantor Inc.

    Announcement: Moody's announces completion of a periodic review of ratings of Phoenix Guarantor Inc. New York, March 21, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Phoenix Guarantor Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Moody's

    Phoenix Guarantor Inc. -- Moody's: Phoenix Guarantor's bolt-on acquisition raises integration risk - ratings unaffected

    Moody's Investors Service commented that Phoenix Guarantor Inc.'s bolt-on acquisition of a regional provider of institutional pharmacy services raises integration risk, a credit negative. For additional information please refer to Moody's Issuer Comment on Phoenix Guarantor Inc. available on www.moodys.com.

  • Moody's

    Phoenix Guarantor Inc. -- Moody's assigns B2 CFR to Phoenix Guarantor Inc., outlook stable

    Moody's Investors Service ("Moody's") assigned a B2 Corporate Family Rating (CFR) and B2-PD Probability of Default Rating to Phoenix Guarantor, Inc. ("PGI"). Moody's also assigned a B1 rating to the company's proposed senior secured first lien credit facilities and a Caa1 rating to its secured second lien credit facility.

  • Moody's

    PharMerica Corporation -- Moody's places PharMerica's ratings under review for downgrade

    Moody's Investors Service ("Moody's") placed the ratings of PharMerica Corporation ("PharMerica"), including the B2 Corporate Family Rating (CFR), under review for downgrade. This follows the announcement that Pharmerica, majority owned by Kohlberg Kravis and Roberts & Co. LP (KKR), will be merged with BrightSpring Health Services ("BrightSpring", unrated). The continued relationship with Walgreens Boots Alliance, Inc. ("Walgreens"), following the merger, will be a positive consideration.